Indication
Progressive pulmonary fibrosis
Progressive pulmonary fibrosis is a clinical phenotype characterized by the relentless worsening of fibrotic lung disease in patients with an interstitial lung disease (ILD) other than idiopathic pulmonary fibrosis. Read more about Progressive pulmonary fibrosis
13 drugs 12 manufacturers
Drugs that treat it
Common Progressive pulmonary fibrosis therapies.
NINTEDANIB ESYLATE
NINTEDANIB ESYLATE
NINTEDANIB ESYLATE
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonProgressive pulmonary fibrosis is a clinical phenotype characterized by the relentless worsening of fibrotic lung disease in patients with an interstitial lung disease (ILD) other than idiopathic pulmonary fibrosis.
It affects the respiratory system across diverse populations, occurring as a complication of varied conditions including autoimmune or connective tissue diseases, fibrotic hypersensitivity pneumonitis, idiopathic nonspecific interstitial pneumonia, and unclassifiable ILDs.
Pathophysiologically, it features self-sustaining alveolar architecture destruction, fibroproliferation, and excessive extracellular matrix deposition.
Clinically, it is defined by the occurrence of at least two of three criteria within the preceding year without an alternative explanation: worsening respiratory symptoms, physiological disease progression (such as absolute decline in forced vital capacity or gas transfer), and radiologic evidence of disease progression on high-resolution computed tomography.
- ajmc.com
Progressive pulmonary fibrosis is a clinical phenotype characterized by the relentless worsening of fibrotic lung disease in patients with an interstitial lung disease (ILD) other than idiopathic pulmonary fibrosis It affects the respiratory system across diverse populations, occurring as a complication of varied conditions including autoimmune or connective tissue diseases, fibrotic hypersensitivity pneumonitis, idiopathic nonspecific interstitial pneumonia, and unclassifiable ILDs
- nih.gov
Progressive pulmonary fibrosis is a clinical phenotype characterized by the relentless worsening of fibrotic lung disease in patients with an interstitial lung disease (ILD) other than idiopathic pulmonary fibrosis It affects the respiratory system across diverse populations, occurring as a complication of varied conditions including autoimmune or connective tissue diseases, fibrotic hypersensitivity pneumonitis, idiopathic nonspecific interstitial pneumonia, and unclassifiable ILDs Pathophysiol...
- tuberktoraks.org
Pathophysiologically, it features self-sustaining alveolar architecture destruction, fibroproliferation, and excessive extracellular matrix deposition
- nih.gov
Clinically, it is defined by the occurrence of at least two of three criteria within the preceding year without an alternative explanation: worsening respiratory symptoms, physiological disease progression (such as absolute decline in forced vital capacity or gas transfer), and radiologic evidence of disease progression on high-resolution computed tomography
- nih.gov
Clinically, it is defined by the occurrence of at least two of three criteria within the preceding year without an alternative explanation: worsening respiratory symptoms, physiological disease progression (such as absolute decline in forced vital capacity or gas transfer), and radiologic evidence of disease progression on high-resolution computed tomography
Personalize your experience
Follow Progressive pulmonary fibrosis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.